Search results for " scales"

showing 10 items of 493 documents

Online Self-Help as an Add-On to Inpatient Psychotherapy: Efficacy of a New Blended Treatment Approach.

2017

<b><i>Background:</i></b> Depression is one of the most frequent and costly mental disorders. While there is increasing evidence for the efficacy of online self-help to improve depression or prevent relapse, there is little evidence in blended care settings, especially combined with inpatient face-to-face psychotherapy. Therefore, we evaluated whether an evidence-based online self-help program improves the efficacy of inpatient psychotherapy. <b><i>Methods:</i></b> A total of 229 depressed patients were randomly allocated either to an online self-help program (intervention group [IG]; Deprexis) or an active control group (CG; weekly online inf…

AdultMalemedicine.medical_specialty020205 medical informaticsDepression Efficacy Inpatient treatment Internet-based treatment Psychosomatic medicine Psychotherapy Randomized controlled trialDysfunctional family02 engineering and technologylaw.invention03 medical and health sciencesDepression Wirksamkeit stationäre Behandlung internetbasierte Behandlung Psychosomatische Medizin Psychotherapie randomisierte kontrollierte Studie0302 clinical medicineQuality of lifeRandomized controlled triallawIntervention (counseling)0202 electrical engineering electronic engineering information engineeringmedicineHumansddc:610PsychiatryApplied PsychologyDepression (differential diagnoses)Psychiatric Status Rating ScalesPsychodynamic psychotherapyDepressive DisorderInpatientsInternetbusiness.industryPsychosomatic medicineGeneral MedicineMiddle Aged030227 psychiatrySelf CarePsychiatry and Mental healthClinical PsychologyTreatment OutcomeTherapy Computer-AssistedAnxietyFemalemedicine.symptombusinessPsychotherapy PsychodynamicPsychotherapy and psychosomatics
researchProduct

Adherence predictors in an Internet-based Intervention program for depression

2017

Internet-delivered psychotherapy has been demonstrated to be effective in the treatment of depression. Nevertheless, the study of the adherence in this type of the treatment reported divergent results. The main objective of this study is to analyze predictors of adherence in a primary care Internet-based intervention for depression in Spain. A multi-center, three arm, parallel, randomized controlled trial was conducted with 194 depressive patients, who were allocated in self-guided or supported-guided intervention. Sociodemographic and clinical characteristics were gathered using a case report form. The Mini international neuropsychiatric interview diagnoses major depression. Beck Depressio…

AdultMalemedicine.medical_specialtyAdolescent020205 medical informaticsPsychological intervention02 engineering and technologylaw.inventionprimary careYoung Adult03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifelawIntervention (counseling)0202 electrical engineering electronic engineering information engineeringHumansMedicineadherencePsychiatryCase report formDepression (differential diagnoses)AgedMini-international neuropsychiatric interviewPsychiatric Status Rating ScalesDepressive Disorder MajorInternetPrimary Health Carebusiness.industryBeck Depression InventoryMiddle AgedInternet-based intervention030227 psychiatryPsychotherapyClinical PsychologyTherapy Computer-AssisteddepressionQuality of LifePatient ComplianceFemalebusinessClinical psychologyCognitive Behaviour Therapy
researchProduct

Virtual reality exposure and imaginal exposure in the treatment of fear of flying: a pilot study

2013

Fear of flying (FF) is an impairing psychological disorder that is extremely common in developed countries. The most effective treatment for this particular type of phobia is exposure therapy. However, there are few studies comparing imaginal exposure (IE) and virtual reality (VR) exposure for the treatment of FF. The present study compared the effectiveness of these two approaches using two manualized interventions based on the exposure technique. Patients with FF ( N = 15) were randomly assigned to either VR ( n = 7) or IE therapy ( n = 8), consisting of a total of eight sessions: two assessment sessions (pre-treatment and after the real flight) and six exposure therapy sessions, which w…

AdultMalemedicine.medical_specialtyAdolescentAircraftmedicine.medical_treatmentExposure therapyPsychological interventionImplosive TherapyPilot ProjectsVirtual realityVirtual realityVirtual Reality Exposure TherapyFear of flyingArts and Humanities (miscellaneous)Fear of flyingImaginal exposureDevelopmental and Educational PsychologymedicinePresenceEffective treatmentHumansPsychiatryAgedPsychiatric Status Rating ScalesVirtual Reality Exposure TherapyMiddle Agedmedicine.diseaseClinical PsychologyPhobic DisordersImaginal capabilityPhysical therapyAnxietyImplosive TherapyFemalemedicine.symptomPsychology
researchProduct

Risperidone Versus Haloperidol and Amitriptyline in the Treatment of Patients With a Combined Psychotic and Depressive Syndrome

1998

In a multicenter, double-blind, parallel group trial, the efficacy of risperidone (RIS) was compared with a combination of haloperidol and amitriptyline (HAL/AMI) over 6 weeks in patients with coexisting psychotic and depressive symptoms with either a schizoaffective disorder, depressive type, a major depression with psychotic features, or a nonresidual schizophrenia with major depressive symptoms according to DSM-III-R criteria. A total of 123 patients (62 RIS; 61 HAL/AMI) were included; the mean daily dosage at endpoint was 6.9 mg RIS versus 9 mg HAL combined with 180 mg AMI. Efficacy results for those 98 patients (47 RIS; 51 HAL/AMI) who completed at least 3 weeks of double-blind treatme…

AdultMalemedicine.medical_specialtyAdolescentAmitriptylineSchizoaffective disorderAntidepressive Agents Tricycliclaw.inventionDouble-Blind MethodExtrapyramidal symptomsRandomized controlled triallawInternal medicineBrief Psychiatric Rating ScalemedicineHaloperidolHumansPharmacology (medical)AmitriptylinePsychiatryAgedPsychiatric Status Rating ScalesDepressive DisorderRisperidoneMiddle AgedRisperidonemedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaHaloperidolFemalemedicine.symptomPsychologyAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Requestioning depression in patients with cancer: Contribution of somatic and affective symptoms to Beck's Depression Inventory

2007

Background: Depressive symptoms are a major complaint reported by cancer patients. Somatic and affective symptoms can contribute to depression. Patients and methods: We investigated the prevalence of somatic and affective depressive symptoms with the Beck Depression Inventory (BDI) in 213 hospitalized cancer patients prior to the start of chemotherapy. Results: Seventeen of 213 patients (8%) were screened positive for major depression; 40 (19%) had mild to moderate depressive symptoms. The corresponding figures for somatic and affective symptoms were 33.3% and 2.8% in the patients with major depression and 23.0% and 8.0% in those with mild to moderate depressive symptoms. Female patients, p…

AdultMalemedicine.medical_specialtyAdolescentComorbidityRisk AssessmentStatistics NonparametricHospitals UniversityAge DistributionQuality of lifeGermanyNeoplasmsSickness Impact ProfileSurveys and QuestionnairesInternal medicineAdaptation PsychologicalInterview PsychologicalPrevalencemedicineHumansSex DistributionPsychiatryDepression (differential diagnoses)AgedProbabilityPsychiatric Status Rating ScalesDepressive Disorderbusiness.industryCase-control studyBeck Depression InventoryCancerHematologyMiddle Agedmedicine.diseaseComorbidityChemotherapy regimenCausalityOncologyCase-Control StudiesQuality of LifeMajor depressive disorderFemalebusinessStress PsychologicalFollow-Up StudiesAnnals of Oncology
researchProduct

Dose-Related Effects of Amisulpride on Five Dimensions of Psychopathology in Patients With Acute Exacerbation of Schizophrenia

2002

The present analysis investigated symptom-specific dose-response relationships of the atypical antipsychotic amisulpride (AMI) in schizophrenic patients. The effects of different AMI doses on five different symptom dimensions of the Brief Psychiatric Rating Scale (BPRS) were analyzed. Results on global efficacy and safety parameters have been previously published. Four AMI doses (100 mg/day [AMI100], 400 mg/day [AMI400], 800 mg/day [AMI800], 1200 mg/day) were compared with 16 mg haloperidol (HAL16) in a multicenter, double-blind, randomized, parallel-group, 4-week trial. A total of 319 patients with acute exacerbation of schizophrenia (DSM-III-R) were included. AMI100 was compared with the …

AdultMalemedicine.medical_specialtyAdolescentExacerbationmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticInternal medicineBrief Psychiatric Rating ScalemedicineHaloperidolHumansPharmacology (medical)AmisulpridePsychiatryAntipsychoticPsychiatric Status Rating ScalesDose-Response Relationship DrugDopamine antagonistMiddle AgedPsychiatry and Mental healthTreatment OutcomeSchizophreniaHaloperidolAnxietyFemaleSchizophrenic PsychologyAmisulprideSulpiridemedicine.symptomPsychologyAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

An interdisciplinary study towards a multiaxial classification of male sexual dysfunction

1991

The classification of male sexual dysfunction (SD) was investigated in a multidisciplinary study involving a sample of 25 outpatients whose phenomenology, course and biologic comorbidity is described. All 25 patients were suffering from arousal disorders; 9 men complained of lack of desire and 9 of orgasm disorders. For the vast majority (19/25), the arousal disorder preceded the other sexual dysfunctions. Eleven patients suffered from a psychopathological disorder according to DSM-III or DSM-III-R (Axis I and II), with general anxiety, major depression and obsessive-compulsive personality being the most common disorders. Only 6 patients were free of any organic disorder or pathological lab…

AdultMalemedicine.medical_specialtyAdolescentLibidomedia_common.quotation_subjectArousalDiagnosis DifferentialErectile DysfunctionRisk FactorsmedicineHumansPersonalityOrgasmPsychiatryPathologicalmedia_commonPatient Care TeamPsychiatric Status Rating ScalesMiddle Agedmedicine.diseasePsychophysiologic DisordersComorbidityPsychiatry and Mental healthSexual dysfunctionAnxietymedicine.symptomPsychologyAnxiety disorderPsychopathologyActa Psychiatrica Scandinavica
researchProduct

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depressi…

2003

OBJECTIVE Current clinical knowledge holds that antidepressants have a delayed onset of efficacy. However, the delayed onset hypothesis has been questioned recently by survival analytical approaches. We aimed to test whether early improvement under antidepressant treatment is a clinically useful predictor of later stable response and remission. METHOD We analyzed data from a randomized double-blind controlled trial with mirtazapine and paroxetine in patients with major depression (DSM-IV). Improvement was defined as a 17-item Hamilton Rating Scale for Depression (HAM-D-17) score reduction of > or = 20%. Stable response was defined as > or = 50% HAM-D-17 score reduction at week 4 and week 6,…

AdultMalemedicine.medical_specialtyAdolescentMirtazapineMirtazapineMianserinAntidepressive Agents TricyclicDrug Administration Schedulelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineAmbulatory CareHumansPsychiatrySurvival analysisDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedPrognosisParoxetineSurvival AnalysisClinical trialPsychiatry and Mental healthParoxetineTreatment OutcomeAntidepressantDrug Therapy CombinationFemalePsychologySelective Serotonin Reuptake Inhibitorsmedicine.drug
researchProduct

Screening for Hypochondriasis With the Illness Attitude Scales

2010

The Illness Attitude Scales (IAS; Kellner, 1986, 1987) may prove highly useful for the screening of hypochondriasis. We expected the IAS subscales to be equally as effective as the 7-item short version of the Whiteley Index (Whiteley-7; Fink et al., 1999), which has previously been shown to be useful in screening for somatoform disorders. We investigated participants of a German population (n = 1,575) and 61 patients with the Diagnostic and Statistical Manual of Mental Disorders (4th ed. [DSM-IV]; American Psychiatric Association, 1994) diagnosis of hypochondriasis. The Bodily Preoccupations (BP) subscale showed high sensitivity (.92) and specificity (.90) as well as demonstrating convergen…

AdultMalemedicine.medical_specialtyAdolescentPersonality InventoryPsychometricsValidation testHealth Toxicology and MutagenesisTest validitySensitivity and SpecificityYoung AdultSex FactorsArts and Humanities (miscellaneous)German populationGermanymedicineHumansPsychiatryAgedAged 80 and overPsychiatric Status Rating ScalesAge FactorsDiscriminant validityReproducibility of ResultsMiddle AgedHypochondriasisClinical PsychologyConvergent validityPsychiatric status rating scalesEducational StatusFemalePersonality Assessment InventoryPsychologyJournal of Personality Assessment
researchProduct

Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.

1997

Several concepts of minor depression in the sense of acute but less severe symptomatology than major depression have been proposed in the literature, but currently none of them is generally accepted. For the treatment of these conditions, only few recommendations based on empirical data are available. We conducted a randomized double-blind multicentre study in depressed outpatients comparing paroxetine and maprotiline in both patients with minor (n = 245) and major depression (n = 298). For the diagnosis, Research Diagnostic Criteria were used in a modified version. Two response criteria were applied: a reduction of 50% or more in total HAMD-17 scores from baseline (criterion 1), and a redu…

AdultMalemedicine.medical_specialtyAdolescentPersonality InventoryResearch Diagnostic CriteriaPlaceboSeverity of Illness IndexXerostomiaDouble blindPlacebosPharmacotherapyDouble-Blind MethodInternal medicinemedicineHumansMaprotilinePsychiatryDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderMiddle AgedParoxetinePsychiatry and Mental healthClinical PsychologyParoxetineTreatment OutcomeMaprotilineAntidepressantFemalePsychologymedicine.drugJournal of affective disorders
researchProduct